130 related articles for article (PubMed ID: 8899089)
21. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
Albillos A; García-Pagán JC; Iborra J; Bandi JC; Cacho G; Pérez-Paramo M; Escorsell A; Calleja JL; Escartín P; Bosch J
Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
[TBL] [Abstract][Full Text] [Related]
22. Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.
Sundberg S; Lehtonen L
Eur J Clin Pharmacol; 2000; 55(11-12):793-9. PubMed ID: 10805056
[TBL] [Abstract][Full Text] [Related]
23. Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis.
Lin HC; Huang YT; Cheng YR; Hou MC; Lee FY; Chang FY; Tsai YT; Lee SD
Clin Sci (Lond); 1998 Jun; 94(6):645-50. PubMed ID: 9854463
[TBL] [Abstract][Full Text] [Related]
24. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
25. Direct measurement of post-prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent-shunt.
Stanley AJ; Forrest EH; Redhead DN; Bouchier IA; Hayes PC
Eur J Gastroenterol Hepatol; 1998 May; 10(5):393-7. PubMed ID: 9619385
[TBL] [Abstract][Full Text] [Related]
26. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
[TBL] [Abstract][Full Text] [Related]
27. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Bosch J
P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
[TBL] [Abstract][Full Text] [Related]
28. Effect and mechanism of action of isosorbide-5-mononitrate.
Hayes PC; Westaby D; Williams R
Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
[TBL] [Abstract][Full Text] [Related]
29. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
Kumar A; Jha SK; Sharma P; Dubey S; Tyagi P; Sharma BC; Sarin SK
Gastroenterology; 2009 Sep; 137(3):892-901, 901.e1. PubMed ID: 19481079
[TBL] [Abstract][Full Text] [Related]
30. Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in partial portal vein ligated rats.
Van de Casteele M; Van Roey G; Nevens F; Fevery J
Hepatology; 1996 Dec; 24(6):1492-6. PubMed ID: 8938186
[TBL] [Abstract][Full Text] [Related]
31. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
[TBL] [Abstract][Full Text] [Related]
32. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt.
Brensing KA; Hörsch M; Textor J; Schiedermaier P; Raab P; Schepke M; Strunk H; Schild H; Sauerbruch T
Scand J Gastroenterol; 2002 Sep; 37(9):1070-6. PubMed ID: 12374234
[TBL] [Abstract][Full Text] [Related]
34. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Navasa M; Chesta J; Bosch J; Rodés J
Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
[TBL] [Abstract][Full Text] [Related]
35. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
Cervinka J; Kordac V; Kalab M
J Int Med Res; 1989; 17(6):560-4. PubMed ID: 2628133
[TBL] [Abstract][Full Text] [Related]
36. Effect of isosorbide dinitrate on gastric blood flow in rats with liver cirrhosis determined by analyzing gastric blood flow, portal vein pressure and blood gas.
Takiguchi F; Irisawa A; Saito A; Sakamoto H; Obara K; Kasukawa R; Ohira H
Fukushima J Med Sci; 2006 Dec; 52(2):111-24. PubMed ID: 17427762
[TBL] [Abstract][Full Text] [Related]
37. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
García-Pagán JC; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
[TBL] [Abstract][Full Text] [Related]
38. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
[TBL] [Abstract][Full Text] [Related]
39. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
40. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
Zoli M; Marchesini G; Brunori A; Cordiani MR; Pisi E
Hepatology; 1986; 6(6):1248-51. PubMed ID: 2878867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
